Gonadotropin treatment restores in vitro interleukin-1β and tumour necrosis factor-α production by stimulated peripheral blood mononuclear cells from patients with idiopathic hypogonadotropic hypogonadism

Clinical and Experimental Immunology

Volumn 132, Issue 2, 2003, Pages 265-270

  Musabak, U ^a   Bolu, E ^a   Ozata, M ^a   Oktenli, C ^a   Sengul, A ^a   Inal, A ^a   Yesilova, Z ^a   Kilciler, G ^a   Ozdemir, I C ^a   Kocar, I H ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Gonadotropin treatment; Hypogonadism; IL 1 ; Monocyte; Testosterone; TNF

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; LUTEINIZING HORMONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; HORMONAL THERAPY; HORMONE DEFICIENCY; HUMAN; HUMAN CELL; HYPOGONADOTROPIC HYPOGONADISM; IDIOPATHIC DISEASE; IN VITRO STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN; GONADOTROPINS, PITUITARY; HUMANS; HYPOGONADISM; INTERLEUKIN-1; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MENOTROPINS; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC; TESTOSTERONE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037541416     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02141.x     Document Type: Article

References (49)

1. Yesilova Z, Ozata M, Kocar IH et al. The effects of gonadotropin treatment on the immunological features of male patients with idiopathic hypogonadotrpic hypogonadism. J Clin Endocrinol Metab 2000; 85:66-70.
2. Oktenli C, Yesilova Z, Kocar IH et al. Study of autoimmunity in Klinefelter's syndrome and idiopathic hypogonadotropic hypogonadism. J Clin Immunol 2002; 22:137-43.
3. Kocar IH, Yesilova Z, Ozata M et al. The effect of testosterone replacement treatment on immunological features of patients with Klinefelter's syndrome. Clin Exp Immunol 2000; 121:448-52.
4. Whitacre CC, Reingold SC, O'Looney PA. Task force on gender, multiple sclerosis and autoimmunity. A gender gap in autoimmunity. Science 1999; 283:1277-8.
5. Olsen NJ, Kovacs WJ. Gonadal steroids and immunity. Endocrinol Rev 1996; 17:369-84.
6. Ahmed SA, Penhale WJ, Talal N. Sex hormones, immune responses, and autoimmune diseases. Am J Pathol 1985; 121:531-51.
7. Miller L, Hunt JS. Sex steroids, hormones and macrophage function. Life Sci 1996; 59:1-14.
8. Grossman CJ. Interactions between the gonadal steroids and the immune system. Science 1985; 227:257-61.
9. Ansar Ahmed S, Daupninee M, Talal N. Effects of short term administration of sex hormones on normal and autoimmune mice. J Immunol 1985; 134:204-10.
10. Ozata M, Ozisik G, Caglayan S et al. Effects of gonadotropin and testosterone treatments on plasma leptin levels in male patients with idiopathic hypogonadotropic hypogonadism and Klinefelter's syndrome. Horm Metab Res 1998; 30:266-71.
11. Polan ML, Daniele A, Kuo A. Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity. Fertil Steril 1988; 49:964.
12. Homo-Delarche F, Fitzpatrick F, Christeff N, Nunez EA, Bach JF, Dardenne M. Sex steroids, glucocorticoids, stress and autoimmunity. J Steroid Biochem Mol Biol 1991; 40:619.
13. Kanda N, Tsuchida T, Tamaki K. Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40:1703-11.
14. Li ZG, Danis VA, Brooks PM. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheum 1993; 11:157-62.
15. Polan ML, Loukides J, Nelson P, Carding S, Diamond M, Walsh A, Bottomly K. Progesterone and estradiol modulate interleukin 1-beta messenger ribonucleic acid levels in cultured human peripheral monocytes. J Clin Endocrinol Metab 1989; 69:1200-6.
16. Gilmore W, Weiner LP, Correale J. Effects of estradiol on cytokine secretion of by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1997; 158:446-51.
17. Arai KI, Lee F, Miyajima A et al. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem 1990; 59:783-836.
18. Dinarello CA. Role of interleukin-1 in infectious diseases. Immunol Rev 1992; 127:119-46.
19. Vasalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992; 10:411-52.
20. Shi FD, Ljunggren HG, Sarvetnick N. Innate immunity and autoimmunity from self-protection to self-destruction. Trends Immunol 2001; 22:97-101.
21. van der Bruggen T, Nijenhuis S, van Raaij E et al. Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the raf-1/MEK1-MEK2/ERK1-ERK2 pathway. Infect Immun 1999; 67:3824-9.
22. Henderson. J. On the relationship of thymus to the sexual organs. I. The influence of castration on the thymus. J Physiol 1994; 31:222-9.
23. Holstock G, Chastenay BF, Krawitt EL. Effects of testosterone, oestradiol and progesterone on immune regulation. Clin Exp Immunol 1982; 47:449-56.
24. Wilson CA, Mrose SA, Thomas DW. Enhanced production of B-lymphocytes after castration. Blood 1995; 85:1535-9.
25. Aboudkhil S, Bureau JP, Garrelly L, Vago P. Effects of castration, depo-testosterone and cyproterone acetate on lymphocyte T subsets in mouse thymus and spleen. Scand J Immunol 1991; 36:647-53.
26. Olsen NJ, Kovacks WJ. Increased thymic size and thymocyte interleukin-2 production in androgen resistant mice. Scand J Immunol 1989; 29:733-8.
27. Olsen NJ, Viselli SM, Shuls K, Stelzer G, Kovacks WJ. Induction of immature thymocyte proliferation after castration of normal male mice. Endocrinology 1994; 134:107-13.
28. Cutolo M, Balleari E, Giusti M, Intra E, Accardo S. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum 1991; 34:1-5.
29. Ariga H, Edwards J, Sullivan DA. Androgen control of autoimmune expression in lacrimal glands of MRL/Mp-1pr/LPR mice. Clin Immunol Immunopathol 1989; 53:499-508.
30. Harbuz MS, Perveen-Gill Z, Lightman SL, Jessop DS. A protective role for testosterone in adjuvant induced arthritis. Br J Rheumatol 1995; 34:1117-22.
31. Sullivan DA. Sex hormones and Sjögren's syndrome. J Rheumatol 1997; 24:17-32.
32. Van Vollenhoven RF, Engleman EG, McGuire JL. An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum 1994; 37:1305-10.
33. Stern R, Fishman J, Brusman H, Kunkel HG. Systemic lupus erythematosus associated with Klinefelter's syndrome. Arthritis Rheum 1977; 20:18.
34. French MAH, Hughes P. Systemic lupus erythematosus and Klinefelter's syndrome. Ann Rheum Dis 1983; 42:471-3.
35. O'Donoghue DJ. Klinefelter's syndrome associated with systemic sclerosis. Postgrad Med 1982; 58:575.
36. Kobayashi S, Shimamoto T, Taniguchi O, Hashimoto H, Hirose S. Klinefelter's syndrome associated with progressive systemic sclerosis: report of a case and review of literature. Clin Rheumatol 1991; 10:84.
37. Ishirara K, Yoshimura M, Nakao H, Kanakura Y, Kanayama Y, Matsuzawa Y. T cell abnormalities in mixed connective tissue disease complicated with Klinefelter's syndrome. Intern Med 1994; 33:714-7.
38. Olsen NJ, Kovacks WJ. Case report: testosterone treatment of SLE in a patient with Klinefelter's syndrome. Am J Med Sci 1995; 310:158-60.
39. Bizzarro A, Valentini G, Di Martino G et al. Influence of testosterone therapy on clinical and immunological features of autoimmune diseases associated with Klinefelter's syndrome. J Clin Endocrinol Metab 1987; 64:32-6.
40. Chao T-Z, Van Alten PJ, Greager JA, Walter RJ. Steroid sex hormones regulate the release of tumor necrosis factor by macrophages. Cell Immunol 1995; 160:43-9.
41. Padgett DA, Loria RM. Endocrine regulation of murine macrophage function: effects of dehydroepiandrosterone, androstenediol and androstenetriol. J Neuroimmunol 1998; 84:61-8.
42. D'Agostino P, Milano S, Barbera C et al. Sex hormones modulate inflammatory mediators produced by macrophages. Ann NY Acad Sci 1999; 876:426-9.
43. Spinedi E, Suesun MO, Hadid R, Daneva T, Gaillard RC. Effects of gonadectomy and sex hormone therapy on the endotoxin-stimulated hypothalamo- pituitary-adrenal axis: evidence for a neuroendocrine-immunological sexual dimorphism. Endocrinology 1992; 131:2430-6.
44. Ben-Nathan D, Padgett DA, Loria RM. Androstenediol and dehydroepiandrosterone protect mice against lethal bacterial infections and lipopolysaccharide toxicity. J Med Microbiol 1999; 48:425-31.
45. Danenberg HD, Alpert G, Lustig S, Ben-Nathan D. Dehydroepiandrosterone protect mice from endotoxin toxicity and reduces tumor necrosis factor production. Antimicrob Agents Chemother 1992; 36:2275-9.
46. Mori H, Nakagawa M, Itoh N, Wada K, Tamaya T. Danazol suppresses the production of interleukin-1α and tumor necrosis factor by human monocytes. Am J Reprod Immunol 1990; 24:45-50.
47. Viselli SM, Stanziale S, Shuls K et al. Castration alters peripheral immune function in normal male mice. Immunology 1995; 84:337-42.
48. Olsen NJ, Wason MB, Kovacks WJ. Studies of immunological function in mice with defective androgen action. Distinction between alterations in immune function due to hormonal insensitivity and alterations due to other genetic factors. Immunology 1991; 73:52-7.
49. Araneo BA, Dowell T, Diegel M, Daynes RA. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and γ-interferon, but not IL-2 by activated murine T cells. Blood 1991; 78:688-99.